1. Academic Validation
  2. A human immunodeficiency syndrome caused by mutations in CARMIL2

A human immunodeficiency syndrome caused by mutations in CARMIL2

  • Nat Commun. 2017 Jan 23;8:14209. doi: 10.1038/ncomms14209.
T Schober 1 T Magg 1 M Laschinger 2 M Rohlfs 1 N D Linhares 3 J Puchalka 1 T Weisser 2 K Fehlner 2 J Mautner 4 5 6 C Walz 7 K Hussein 8 G Jaeger 9 B Kammer 1 I Schmid 1 M Bahia 10 S D Pena 3 U Behrends 4 5 6 B H Belohradsky 1 C Klein 1 6 F Hauck 1 6
Affiliations

Affiliations

  • 1 Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität (LMU), Lindwurmstrasse 4, D-80337 Munich, Germany.
  • 2 Department of Surgery, Technische Universität München (TUM), Ismaninger Strasse 22, D-81675 Munich, Germany.
  • 3 Laboratory of Clinical Genomics, Federal University of Minas Gerais, 190 Professor Alfredo Balena Avenida, Belo Horizonte 30130-100, Brazil.
  • 4 Research Unit Gene Vectors, Helmholtz Zentrum München (HMGU)-German Research Center for Environmental Health, Marchioninistrasse 25, D-81377 Munich, Germany.
  • 5 Children's Hospital, Technische Universität München (TUM), Munich D-80804, Germany.
  • 6 German Centre for Infection Research (DZIF), Trogerstrasse 30, D-81675 Munich, Germany.
  • 7 Institute of Pathology, Ludwig-Maximilians-Universität (LMU), Thalkirchner Strasse 36, D-80337 Munich, Germany.
  • 8 Institute of Pathology, Hannover Medical School (MHH), Carl-Neuberg-Strasse 1, D-30625 Hanover, Germany.
  • 9 Department of Diagnostic Virology, Max von Pettenkofer-Institute, Ludwig-Maximilians-Universität (LMU), Pettenkoferstrasse 9a, D-80336 Munich, Germany.
  • 10 Department of Pediatric Gastroenterology, Federal University of Minas Gerais, 110 Prof. Alfredo Balena Avenida, Belo Horizonte 30130-100, Brazil.
Abstract

Human T-cell function is dependent on T-cell antigen receptor (TCR) and co-signalling as evidenced by immunodeficiencies affecting TCR-dependent signalling pathways. Here, we show four human patients with EBV+ disseminated smooth muscle tumours that carry two homozygous loss-of-function mutations in the CARMIL2 (RLTPR) gene encoding the capping protein regulator and Myosin 1 linker 2. These patients lack regulatory T cells without evidence of organ-specific autoimmunity, and have defective CD28 co-signalling associated with impaired T-cell activation, differentiation and function, as well as perturbed cytoskeletal organization associated with T-cell polarity and migration disorders. Human CARMIL2-deficiency is therefore an autosomal recessive primary immunodeficiency disorder associated with defective CD28-mediated TCR co-signalling and impaired cytoskeletal dynamics.

Figures